These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3460528)

  • 21. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
    Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
    Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tumor markers in human breast cancer].
    Takami H; Shikata J
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and immunologic diagnosis of cancer. Colorectal cancer.
    von Kleist S
    Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
    Mennini G; Silecchia G; Zanna C; Cucchiara G; Spadaro G; Greco E; Basoli A; Speranza V
    Ital J Surg Sci; 1985; 15(1):37-43. PubMed ID: 3858272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen in gastrointestinal neoplasms. Comparison of markers].
    Capocasale E; Contini S; Rossetti A; Del Sante G; Gregori G
    Acta Biomed Ateneo Parmense; 1985; 56(6):231-6. PubMed ID: 2940782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tumor markers in the management of colorectal cancer.
    Go VL; Zamcheck N
    Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
    Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
    Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
    Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE
    Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of blood carcinoembryonic antigen (CEA) in the diagnosis and follow-up of tumors of the stomach and large intestine].
    Lorusso D; Lacitignola S; Giorgio P; Sisto G
    Minerva Dietol Gastroenterol; 1984; 30(2):191-6. PubMed ID: 6472702
    [No Abstract]   [Full Text] [Related]  

  • 32. Tumor markers for cancer detection. II.
    Pluygers EP; Beauduin MP; Baldewyns PE; Burion JA
    Cancer Detect Prev; 1986; 9(5-6):505-9. PubMed ID: 3490909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies for carcinoembryonic antigen (CEA) as a model system: identification of two novel CEA-related antigens in meconium and colorectal carcinoma tissue by Western blots and differential immunoaffinity chromatography.
    Neumaier M; Fenger U; Wagener C
    J Immunol; 1985 Nov; 135(5):3604-9. PubMed ID: 4045198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
    Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
    Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content.
    Pagé M; Dalifard I; Bertrand G; Bocquillon PG; Daver A
    Anticancer Res; 1986; 6(5):893-6. PubMed ID: 3541780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and management of colorectal cancer.
    Simon JB
    Compr Ther; 1986 Aug; 12(8):15-9. PubMed ID: 3742993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical antigenic expression and in vivo tumor uptake of monoclonal antibodies with specificity for tumors of the gastrointestinal tract.
    Douillard JY; Lehur PA; Aillet G; Kremer M; Bianco-Arco A; Peltier P; Chatal JF
    Cancer Res; 1986 Aug; 46(8):4221-4. PubMed ID: 3524803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
    Wählby L
    Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
    [No Abstract]   [Full Text] [Related]  

  • 40. [Colonic cancer; problems of early diagnosis. 3. Neoplasm makers].
    Shimano T; Okuda H; Monden T; Morimoto H; Tamaki Y; Shimizu M; Inaji H; Saito M; Mori T
    Nihon Rinsho; 1988 Feb; 46(2):387-91. PubMed ID: 3164077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.